NCT05003505View on ClinicalTrials.gov

Characteristics of Vaginal and Intestinal Microbiota and Cervical HPV Infection

Active, not recruitingOBSERVATIONAL
Enrollment

651

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

August 31, 2024

Study Completion Date

December 31, 2024

Conditions
Intestinal MicrobiotaVaginal MicrobiotaHPV Infection
Interventions
OTHER

Follow up

Participants will be followed up at 6, 12 and 24 months with the test of enous blood, vaginal secretions, faeces, and cervical exfoliated cells.

Trial Locations (8)

350001

Fujian Maternity and Child Health Hospital, Fuzhou

352000

Mindong Hospital of Ningde City, Ningde

361000

Xiamen Maternity and Child Health Hospital Affiliated to Xiamen University, Xiamen

362000

Quanzhou First Hospital Afflicated to Fujian Medical University, Quanzhou

363000

Zhangzhou affiliated Hospital of Fujian Medical University, Zhangzhou

Unknown

Shunde Women's and Children's Hospital of Guangdong Medical University, Foshan

Maternal and Child Health Hospital of Shenzhen Province, Shenzhen

Maternal and Child Health Hospital of Hubei Province, Wuhan

All Listed Sponsors
lead

Fujian Maternity and Child Health Hospital

OTHER